Drugs Causing Photosensitivity
On this page
Direct answer
Two mechanisms cover every exam question on drug photosensitivity. Phototoxicity is direct, dose-dependent tissue injury — exaggerated sunburn with erythema and blistering confined to sun-exposed skin, appearing within minutes to hours; the classic drugs are doxycycline, fluoroquinolones, amiodarone and thiazides. Photoallergy is a delayed, cell-mediated immune response in which light converts a drug into an allergen: eczematous, itchy, spreading beyond exposed sites and persisting after the drug stops; sulphonamides, phenothiazines and thiazides lead that list. Management is stopping or shielding the drug, broad-spectrum sunscreen and topical corticosteroids for the rash — plus, for transplant and long-term voriconazole patients, dedicated skin surveillance because their photosensitivity runs on to skin cancer.
What you must remember
- Phototoxicity list: doxycycline (the signature drug), other tetracyclines, fluoroquinolones (ciprofloxacin, ofloxacin), amiodarone, thiazides, psoralens, voriconazole, retinoids and NSAIDs such as ketoprofen.
- Photoallergy list: sulphonamides, thiazides, phenothiazines (chlorpromazine), quinidine and some sunscreen filters — thiazides appear on both lists, a deliberate exam trap.
- Clinical discrimination: phototoxic = sunburn-like, immediate, dose-dependent, only exposed skin; photoallergic = eczematous, delayed 24-72 hours, spreads beyond exposed areas, cross-reacts with chemically related drugs.
- Voriconazole's special risk: long-term therapy causes phototoxicity, photoaging, actinic keratoses and squamous cell carcinoma — transplant recipients on years of prophylaxis need dermatology follow-up.
- Amiodarone's twin lesions: phototoxicity in up to a quarter of patients, plus a distinct blue-grey dermal dyspigmentation that is not photosensitivity and does not fade quickly.
- Counselling prescription: for every doxycycline course — broad-spectrum SPF sunscreen, protective clothing, and midday sun avoidance; the advice costs nothing and prevents the rash.
- Diagnostics when unclear: photopatch testing for suspected photoallergy; monochromator phototesting in specialised centres for phototoxicity.
- Don't confuse: drug photosensitivity with porphyria cutanea tarda or lupus photosensitivity — vesicles on sun-exposed hands and an appropriate work-up separate them.
A worked clinic case
A 24-year-old on doxycycline for acne returns from a beach holiday with sharply demarcated, burning erythema and tense blisters across the forearms, the V of the neck and the nose — sparing the upper eyelids and submental area, the geometry of sunlight. The diagnosis is phototoxicity: drug plus ultraviolet A (which passes through window glass and most casual sunscreens poorly), dose in the skin, injury in hours. Management is stopping or completing the doxycycline as severity dictates, cool compresses, topical corticosteroids for inflammation, analgesia, and strict photoprotection for the weeks the drug and its metabolites persist in skin.
The second scenario belongs to the transplant clinic: a renal transplant recipient on voriconazole prophylaxis for two years develops freckled sun damage, multiple actinic keratoses on the forehead and a biopsy-proven squamous cell carcinoma of the lip — all on sun-exposed sites. Here photosensitivity is not a rash to treat but a cancer-risk state to manage: switch antifungal where possible, annual (often six-monthly) dermatology review, and relentless sun avoidance. Same mechanism family, entirely different clinical stakes.
How the exam frames it
The question format is nearly always a matching exercise: name the drug, name the mechanism. Doxycycline and fluoroquinolones point to phototoxicity; sulphonamides and phenothiazines point to photoallergy; thiazides can be written on either side and are used precisely to catch candidates who memorised only one column. The voriconazole-squamous carcinoma link is the modern discriminator — it converts a dermatology side-effect question into a transplant-pharmacology question. The Indian-context angle is epidemiological: doxycycline is prescribed massively for acne and for scrub typhus and other rickettsial infections across sun-intense regions, making photoprotection counselling a genuine public-health habit rather than fine print; Indian exam vignettes frequently set the doxycycline question in a farming or field-work context to test whether the candidate volunteers the counselling. One viva-worthy distinction: amiodarone's blue-grey pigmentation is a deposition phenomenon unrelated to light, even though amiodarone also causes true phototoxicity — untangling that earns the mark.
Frequently asked questions
Which drug is the classic cause of phototoxic sunburn-like reactions?
Doxycycline — dose-dependent, confined to sun-exposed skin, occurring within hours of ultraviolet exposure.
How does photoallergic dermatitis differ clinically from phototoxicity?
It is eczematous and itchy, appears 24-72 hours later, may spread beyond exposed skin, and persists after drug withdrawal.
Which antifungal causes photosensitivity leading to skin cancer?
Voriconazole — prolonged use causes photoaging, actinic keratoses and squamous cell carcinoma, mandating dermatological surveillance.
Which drug appears on both phototoxic and photoallergic lists?
Thiazides — used in exams precisely because they produce both patterns.
What counselling accompanies a doxycycline prescription?
Broad-spectrum sunscreen, protective clothing and midday sun avoidance, continued for the duration of therapy and a few weeks after.